Birdwatch Note
2023-03-16 21:32:13 UTC - NOT_MISLEADING
"Under section 564 of the Federal Food, Drug, and Cosmetic Act...FDA may authorize unapproved medical products when certain criteria are met, including there are no adequate, approved, and available alternatives." https://www.fda.gov/emergency-preparedness-and-response/mcm-legal-regulatory-and-policy-framework/emergency-use-authorization
Written by AA4BEAF3AB69D0807295F3D4E5F9D50FC49A82AE25BE220271F7B42AE4275BC9
Participant Details
Original Tweet
Tweet embedding is no longer reliably available, due to the platform's instability (in terms of both technology and policy). If the Tweet still exists, you can view it here: https://twitter.com/foo_bar/status/1634345437560750080
Please note, though, that you may need to have your own Twitter account to access that page. I am currently exploring options for archiving Tweet data in a post-API context.
All Information
- ID - 1636480512805179392
- noteId - 1636480512805179392
- participantId -
- noteAuthorParticipantId - AA4BEAF3AB69D0807295F3D4E5F9D50FC49A82AE25BE220271F7B42AE4275BC9 Participant Details
- createdAtMillis - 1679002333246
- tweetId - 1634345437560750080
- classification - NOT_MISLEADING
- believable -
- harmful -
- validationDifficulty -
- misleadingOther - 0
- misleadingFactualError - 0
- misleadingManipulatedMedia - 0
- misleadingOutdatedInformation - 0
- misleadingMissingImportantContext - 0
- misleadingUnverifiedClaimAsFact - 0
- misleadingSatire - 0
- notMisleadingOther - 0
- notMisleadingFactuallyCorrect - 1
- notMisleadingOutdatedButNotWhenWritten - 0
- notMisleadingClearlySatire - 0
- notMisleadingPersonalOpinion - 0
- trustworthySources - 1
- summary
- "Under section 564 of the Federal Food, Drug, and Cosmetic Act...FDA may authorize unapproved medical products when certain criteria are met, including there are no adequate, approved, and available alternatives." https://www.fda.gov/emergency-preparedness-and-response/mcm-legal-regulatory-and-policy-framework/emergency-use-authorization
Note Status History
| createdAt | timestampMillisOfFirstNonNMRStatus | firstNonNMRStatus | timestampMillisOfCurrentStatus | currentStatus | timestampMillisOfLatestNonNMRStatus | mostRecentNonNMRStatus | participantId |
| 2023-03-16 21:32:13 UTC (1679002333246) |
1969-12-31 23:59:59 UTC (-1) |
2023-03-17 06:38:20 UTC (1679035100346) |
NEEDS_MORE_RATINGS | 1969-12-31 23:59:59 UTC (-1) |
Note Ratings
| rated at | rated by | |
| 2023-03-16 19:19:20 -0500 | Rating Details | |
| 2023-03-16 18:11:39 -0500 | Rating Details | |
| 2023-03-16 17:49:54 -0500 | Rating Details | |
| 2023-03-16 17:40:15 -0500 | Rating Details | |
| 2023-03-16 17:26:10 -0500 | Rating Details | |
| 2023-03-16 16:43:32 -0500 | Rating Details | |
| 2023-03-16 16:33:31 -0500 | Rating Details | |
| 2023-03-17 17:40:57 -0500 | Rating Details | |
| 2023-03-17 17:23:26 -0500 | Rating Details | |
| 2023-03-17 16:53:33 -0500 | Rating Details | |
| 2023-03-17 16:30:02 -0500 | Rating Details | |
| 2023-03-17 15:31:07 -0500 | Rating Details | |
| 2023-03-17 14:53:43 -0500 | Rating Details | |
| 2023-03-17 13:17:55 -0500 | Rating Details | |
| 2023-03-17 12:37:23 -0500 | Rating Details | |
| 2023-03-17 12:20:04 -0500 | Rating Details | |
| 2023-03-17 11:51:39 -0500 | Rating Details | |
| 2023-03-17 09:00:08 -0500 | Rating Details | |
| 2023-03-17 04:00:58 -0500 | Rating Details | |
| 2023-03-17 02:22:27 -0500 | Rating Details | |
| 2023-03-16 23:45:30 -0500 | Rating Details | |
| 2023-03-16 21:09:19 -0500 | Rating Details | |
| 2023-03-16 19:38:03 -0500 | Rating Details | |
| 2023-03-18 14:07:35 -0500 | Rating Details | |
| 2023-03-18 12:43:31 -0500 | Rating Details | |
| 2023-03-18 11:06:11 -0500 | Rating Details | |
| 2023-03-21 18:58:09 -0500 | Rating Details | |
| 2023-03-21 00:31:04 -0500 | Rating Details | |
| 2023-03-22 11:19:25 -0500 | Rating Details | |
| 2023-03-27 18:17:41 -0500 | Rating Details | |
| 2023-03-18 12:43:31 -0500 | Rating Details | |
| 2023-03-18 11:06:11 -0500 | Rating Details | |
| 2023-03-17 16:53:33 -0500 | Rating Details | |
| 2023-03-17 11:51:39 -0500 | Rating Details | |
| 2023-03-17 12:37:23 -0500 | Rating Details | |
| 2023-03-16 19:19:20 -0500 | Rating Details | |
| 2023-03-18 14:07:35 -0500 | Rating Details | |
| 2023-03-16 23:45:30 -0500 | Rating Details | |
| 2023-03-16 16:43:32 -0500 | Rating Details | |
| 2023-03-17 12:20:04 -0500 | Rating Details | |
| 2023-03-17 09:00:08 -0500 | Rating Details | |
| 2023-03-21 18:58:09 -0500 | Rating Details | |
| 2023-03-16 17:49:54 -0500 | Rating Details | |
| 2023-03-22 11:19:25 -0500 | Rating Details | |
| 2023-03-17 14:53:43 -0500 | Rating Details | |
| 2023-03-16 16:33:31 -0500 | Rating Details | |
| 2023-03-17 17:23:26 -0500 | Rating Details | |
| 2023-03-21 00:31:04 -0500 | Rating Details | |
| 2023-03-16 17:40:15 -0500 | Rating Details | |
| 2023-03-17 17:40:57 -0500 | Rating Details | |
| 2023-03-17 15:31:07 -0500 | Rating Details | |
| 2023-03-17 16:30:02 -0500 | Rating Details | |
| 2023-03-16 17:26:10 -0500 | Rating Details | |
| 2023-03-17 04:00:58 -0500 | Rating Details | |
| 2023-03-27 18:17:41 -0500 | Rating Details | |
| 2023-03-17 13:17:55 -0500 | Rating Details | |
| 2023-03-16 18:11:39 -0500 | Rating Details | |
| 2023-03-16 21:09:19 -0500 | Rating Details | |
| 2023-03-17 02:22:27 -0500 | Rating Details | |
| 2023-03-16 19:38:03 -0500 | Rating Details | |
| 2023-07-22 16:46:07 -0500 | Rating Details | |
| 2023-07-23 03:52:36 -0500 | Rating Details |